🫘 Managing hyperphosphatemia in CKD goes beyond phosphate control! Explore comorbidity risks, novel phosphate-lowering therapies, and team-based strategies to improve patient care. 💡 Expand your expertise—learn more! mdsc.pe/4ibH2ni

🩸 Rethink the balance between stroke prevention and bleeding risk. Discover the latest data on emerging anticoagulation strategies, including FXI/XIa inhibitors, and how they may shape future care. 💡 mdsc.pe/4d5V8ov #AAFPFMX

🧭 Spot PAH sooner. Treat with greater confidence. Explore early clues and risk factors 💡for PAH, including METH-PAH, strengthen diagnosis and risk stratification, and tackle titration, tolerability & adherence. 🫀 Elevate your PAH care—secure your spot! mdsc.pe/3UfsbzT

Starting in 1 HOUR ➡️ mdsc.pe/4rPzNWu Ready to streamline non-diabetic CKD care and earn free CME credit? Join our expert-to-expert discussion LIVE. #Nephrology #CME #KidneyDisease

How can medications and cannabis affect driving safety in older adults? Review the latest evidence on polypharmacy, cannabis use, and impairment—and what it may mean for clinical conversations. 🔗 mdsc.pe/4ynC25b

LIVE TOMORROW ➡️ mdsc.pe/4rPzNWu Elevate your non-diabetic CKD management. Join Drs. Cherney & Heerspink LIVE to integrate emerging pharmacotherapies into care. 📅 October 19th ⏰ 12:00 PM ET #Nephrology #CME #CKD

🧬 Could factor XIa inhibition reshape secondary stroke prevention? Explore the science behind targeting factor XI/XIa, review the 🧪 latest trial data & identify patients who may benefit from this emerging approach. 🚀 Stay ahead of the evidence—register! mdsc.pe/4zL8kc1

🔬 Could factor XIa inhibitors change the secondary stroke prevention landscape? 🧠 Examine the latest clinical evidence, who’s being studied in phase 3 trials & what emerging data reveal about benefits and risks. 🛡️ Bring tomorrow’s evidence into focus—save your spot! 👉 mdsc.pe/461BplZ

🧩 CKM syndrome doesn’t fit neatly into one specialty. Recognize overlapping clinical markers, explore the evolving role of nsMRAs, + 🫀translate the latest evidence into primary care. 🫘 Connect the dots, coordinate care & reduce risk👇 mdsc.pe/3SKengb #AAFPFMX

🩸 Rethink the balance between stroke prevention and bleeding risk. Discover the latest data on emerging anticoagulation strategies, including FXI/XIa inhibitors, and how they may shape future care. 💡 mdsc.pe/4d5V8ov #AAFPFMX

🧬 Could factor XIa inhibition reshape secondary stroke prevention? Explore the science behind targeting factor XI/XIa, review the 🧪 latest trial data & identify patients who may benefit from this emerging approach. 🚀 Stay ahead of the evidence—register today! mdsc.pe/4zL8kc1

🚦PAH can be easy to miss—until it isn’t.Sharpen your ability to recognize early signs and METH-PAH risk, use echo and clinical tools for risk stratification, and navigate treatment 💊 titration and tolerability. 🫁 Act earlier—register today! mdsc.pe/3UfsbzT

🚨 Big news! 🚨 We're thrilled to welcome renowned 🫀 cardiologist and former U.S. FDA Commissioner, @DrCaliff_FDA as the 🗝️ Keynote Speaker at the 7th Annual Heart of Cardiology Conference! 👉 Don't miss the opportunity to hear from one of the most influential voices in cardiovascular medicine. 🎟️ Reserve your seat today: mdsc.pe/4gexDLK #HeartofCardio #Cardiology #CardioConference #CME #MedicalEducation

🔬 Could factor XIa inhibitors change the secondary stroke prevention landscape? 🧠 Examine the latest clinical evidence, who’s being studied in phase 3 trials & what emerging data reveal about benefits and risks. 🛡️ Bring tomorrow’s evidence into focus—save your spot! 👉 mdsc.pe/461BplZ

🫀 How can we reduce cardiorenal risk in non-diabetic CKD? Explore emerging evidence, identify high-risk patients, and strengthen long-term management strategies. 🔍 Advance your clinical knowledge—learn more! mdsc.pe/4yRkcbJ

Are routine screening gaps impacting your non-diabetic CKD patient outcomes? Join expert faculty LIVE to learn actionable strategies and improve cardiorenal care. 📅 October 19, 2026 ⏰ 12:00 PM ET 🔗 mdsc.pe/4rPzNWu #Nephrology #CME #KidneyHealth

36th European Meeting on Hypertension, Cardio and Neurovascular Protection xitter.cf/i/broadcasts/1AKEmvrjz…

Starting in 1 HOUR ➡️ mdsc.pe/4hrMguG Master new evidence in hypertension, cardio & neurovascular protection. Join leading expert faculty to elevate your clinical practice. 📅 Today ⏰ 12:00pm ET #Hypertension #Cardiology #CME

🔗 CKM care starts with seeing the connections. Explore overlapping markers seen in primary care, 🩺 uncover where nsMRAs fit into today’s treatment algorithms, and strengthen multidisciplinary strategies for long-term management. ⚙️ Get ahead of cardiorenal risk—secure your spot! mdsc.pe/3SKengb #AAFPFMX

Starting in 1 HOUR ➡️ mdsc.pe/3VHom77 Looking at all the pieces of the hyperphosphatemia puzzle? Join Dr. Matthew Weir & Leah Foster-Smith live. 📅 Today ⏰ 12:30pm ET #Nephrology #CKD #Dialysis